TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
HNGE Stock 12 Month Forecast
Average Price Target
$58.85
▲(6.73% Upside)
Based on 14 Wall Street analysts offering 12 month price targets for Hinge Health, Inc. Class A in the last 3 months. The average price target is $58.85 with a high forecast of $70.00 and a low forecast of $45.00. The average price target represents a 6.73% change from the last price of $55.14.
We recommend investors own HNGE shares on the back of a clean second- quarter beat and strong growth momentum. More specific, we believe Hinge Health is well positioned to capitalize on a strong demand environment for digital MSK solutions, as employers seek cost-savings solutions that also augment the employee experience. The company also continues to extend its market leadership with product innovation (e.g., a network of curated in- person care providers called HingeSelect, announced in mid-June) and new channel partners (e.g., launching with Cigna [CI $270.74] earlier in 2025). The stock has traded well following the IPO, moving up about 50% from the $32 offering price. HNGE shares now trade at approximately 7 times 2026 revenue and 8 times 2026 adjusted gross profit, a discount to mature, high- margin, growth-oriented healthcare IT peers.
We recommend investors own HNGE shares on the back of a clean second- quarter beat and strong growth momentum. More specific, we believe Hinge Health is well positioned to capitalize on a strong demand environment for digital MSK solutions, as employers seek cost-savings solutions that also augment the employee experience. The company also continues to extend its market leadership with product innovation (e.g., a network of curated in- person care providers called HingeSelect, announced in mid-June) and new channel partners (e.g., launching with Cigna [CI $270.74] earlier in 2025). The stock has traded well following the IPO, moving up about 50% from the $32 offering price. HNGE shares now trade at approximately 7 times 2026 revenue and 8 times 2026 adjusted gross profit, a discount to mature, high- margin, growth-oriented healthcare IT peers.
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +25.77% per trade.
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +36.20% per trade.
Copying Saket Kalia's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +36.20% per trade.
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +36.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
HNGE Analyst Recommendation Trends
Rating
Jun 25
Jul 25
Aug 25
Strong Buy
0
0
0
Buy
14
18
32
Hold
0
0
3
Sell
0
0
0
Strong Sell
0
0
0
total
14
18
35
In the current month, HNGE has received 32Buy Ratings, 3Hold Ratings, and 0Sell Ratings. HNGE average Analyst price target in the past 3 months is 58.85.
Each month's total comprises the sum of three months' worth of ratings.
HNGE Financial Forecast
HNGE Earnings Forecast
Next quarter’s earnings estimate for HNGE is $0.09 with a range of $0.06 to $0.11. The previous quarter’s EPS was $0.35. HNGE beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.19% of the time in the same period. In the last calendar year HNGE has Outperformed its overall industry.
Next quarter’s earnings estimate for HNGE is $0.09 with a range of $0.06 to $0.11. The previous quarter’s EPS was $0.35. HNGE beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.19% of the time in the same period. In the last calendar year HNGE has Outperformed its overall industry.
HNGE Sales Forecast
Next quarter’s sales forecast for HNGE is $125.38M with a range of $124.20M to $129.56M. The previous quarter’s sales results were $139.10M. HNGE beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 46.91% of the time in the same period. In the last calendar year HNGE has Outperformed its overall industry.
Next quarter’s sales forecast for HNGE is $125.38M with a range of $124.20M to $129.56M. The previous quarter’s sales results were $139.10M. HNGE beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 46.91% of the time in the same period. In the last calendar year HNGE has Outperformed its overall industry.
HNGE Stock Forecast FAQ
What is HNGE’s average 12-month price target, according to analysts?
Based on analyst ratings, Hinge Health, Inc. Class A’s 12-month average price target is 58.85.
What is HNGE’s upside potential, based on the analysts’ average price target?
Hinge Health, Inc. Class A has 6.73% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HNGE a Buy, Sell or Hold?
Hinge Health, Inc. Class A has a consensus rating of Strong Buy which is based on 14 buy ratings, 0 hold ratings and 0 sell ratings.
What is Hinge Health, Inc. Class A’s price target?
The average price target for Hinge Health, Inc. Class A is 58.85. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $70.00 ,the lowest forecast is $45.00. The average price target represents 6.73% Increase from the current price of $55.14.
What do analysts say about Hinge Health, Inc. Class A?
Hinge Health, Inc. Class A’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of HNGE?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.